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INTERACTION OF CATECHOLAMINE AND AMINO ACID
METABOLISM IN BRAIN: EFFECT OF PARGYLINE
AND L-DOPA
W. J. NICKLAS, 1 S. BERL 1 and D. D. CLARKE
Department of Neurology, College of Physicians and Surgeons, Columbia University, 640 West l68th Street, New York,
NY 10032 and Department of Chemistry, Fordham University, Bronx, NY 10458, U.S.A.

(Received 14 November 1973. Accepted 23 January 1974)
Abstract The combination ofL-DOPA and pargyline caused a decrease in level of aspartate and an increase in that of glutamine in vivo in cerebral cortex, cerebellum, brain stem, hypothalamus, neostriatum
and cervical cord of rat. There was also a decreased incorporation of radioactivity from [l- 14C]acetate
into amino acids in rico, most notably in cerebellum and brain stem. The labelling of glutamine was especially affected. In addition, cortical slices were prepared from guinea p1gs \\ hich ha-d been prctrca ted with
pargyline. These slices were incubated with and without 1 mM L-DOPA in media containing [l- 14C]acetate. Pargyline alone caused a stimulation of the labelling of glutamate and aspartate but not glutamine
and GABA ; the levels of aspartate and GABA were greater than in control slices. The addition ofL-DOPA
to slices from pargylinized animals caused a severe decrease in glutamine labelling but not in that of glutamate or aspartate; the level of glutamine was increased while that of glutamate was decreased. The results
are discussed in terms of the known biochemical and morphological compartmentation of amino acids
in brain. It is suggested that catecholamines, in the process of functioning as transmitters, may also function as metabolic regulators of other transmitters, e.g. amino acids, as well as of the energy required for
balanced neuronal function.

by noradrencrgic terminals (SANTINI & BERL, 1972).
Pargyline also significantly decreased the levels of glutamate, glutamine, aspartate and alanine-glycine in
dorsal root ganglia, but not in sympathetic ganglia
(SANTINJ & BERL, 1972). Lithium salts which influence
noradrenaline in brain alter glutamate metabolistn
both in vivo (DE FCUDIS & DELGADO. 1970) and in L'itro
(BERL & CLARKE, 1972). Intracisternally administered
6-hydroxydopan1ine, which markedly depletes catecholamines throughout the brain with concomitant
destruction of adrenergic nerve terminals. also altered
the labelling of amino acids from [ l- 14C]acetate
(NICKLAS & BERL, 1973). The above data were generally consistent with the gross hypothesis that when an
increased rate of formation of catecholamines is present, the turnover of glutamate, etc is stimulated~ when
the rate of formation is depressed, the turnover of
amino acids is also depressed (NICKLAS & B~ 1973).
The fact that the drugs cited above elicit their effects
on catecholamines by different tnechanisms would indicate that the concomitant effects on amino acids are
more than just trivial ones. However, the exact nature
of these interactions both in terms of the flow of material between metabolic compartments in the brain and
at the molecular level remains somewhat obscure. In
an effort to further evaluate the interrelationship of

EviDENCE continues to accumulate regarding the role
of amino acids as putative transmitters in the central
nervous system (for review see ROBERTS & HAMMERSCHLAG, 1972). Furthermore, the physiological interplay of the excitatory and inhibitory transmitter systems, which interact to maintain behavioral homeostasis and adaptation to environmental parameters,
raises the possibility that biochemical cross-regulation
may exist between catecholamine, acetylcholine,
amino acid and other, as yet undefined, synapses
(ROBERTS & MAITHYSSE, 1970). It is, therefore, of special interest that drugs which alter catecholamine
metabolism, or their uptake and storage mechanisms,
also affect the metabolism of those amino acids proposed as neurotransmitters and associated with the tricarboxylic acid cycle, i.e. glutamate, aspartate and
GABA. Reserpine administered to cats at low doses,
caused a three-fold increase in the rate of metabolism
of these amino acids in cortex, caudate, and thalamus
(BERL & FRIGYESI, 1969). At larger doses of reserpine
the levels of the amino acids were decreased both in
brain and other neuronal structures of the cat supplied
1
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catecholamines and amino acids, the effects of pargyline and pargyline plus L-DOPA on amino acids m
brain was exan1ined in vivo and in vitro.
METHODS AND MATERIALS
In vivo experiments
Male Sprague Dawley rats ( 175-200 g) were injected intraperitoneally with pargyline (tOO mg/ kg) in isotonic saline.
L-DOPA (I 00 mg/kg) was administered intraperitoneally
30 min later. The L-DOPA was prepared as a 20 mgj ml soln
in 0·01 N HCl in isotonic saline and was partially neutralized
with 1N NaOH immediately prior to injection. Control animals received similar volumes of isotonic saline in place of
the pargyline and L-DOPA. At periods ranging from 20 to
4S min after administration of L-DOPA (or saline), the rats
were decapitated, the brains removed and divided into
various brain areas which were frozen in liquid nitrogen
(NICKLAS & BERL, 1973). In some cases, [l- 14C]acetate
(250 11Ci/kg) was administered intraperitoneally lS min after
injection ofL-DOPA (or saline). At periods ranging from S
to 30 min after injection of C4 C]acetate. the animals were
sacrificed and brain samples taken as outlined above. The
amino acids, glutamate, glutamine, aspartate and GABA
were extracted with so~ (wfv) trichloroacetic acid from samples of cerebral cortex, cerebellum. brain stem, hypothalamus, neostriatum and cervical cord. The amino acids were
separated by ion-exchange column chromatography. quantitated with ninhydrin by the Autoanalyzer Sampler plate
technique and radioactivity measured with a Packard liquid
scintillation spectrometer (BERL et a/., 1968; NICKLAS &
BERL, 1973).
In vitro experirnellls
Guinea pigs (2SO g) were injected intra peritoneally with
either pargyline (J 00 mg/kg) in isotonic saline (I 00 mg pargyline/ ml saline) or an appropriate volume of saline. The
animals were decapitated 30 min later and ~lices of cerebral
cortex were prepared as previously described (BERL &
CLARKE, 1971). The slices (60-80 mg wet wt) were preincubated in 2·5 ml Krebs Ringer bicarbonate medium at 3r C
with agitation for JS min. The slice was then transferred to
2·S ml fresh medium and 2·S pCi [l- 14C]acetate (42 J.LCif
J.Lmol) in 20 J.tl saline was added. In some cases, 1 mM LDOPA was present in the preincubation and incubation
media. After incubation at 37°C for S, 10 or 20 min, the
slices were removed from the medium and rapidly homogenized with 2 ml so 0 TCA (wfv). If the amino acids in the
media were to be measured. 0·2 mJ of S0° ~ TCA (wfw) was
mixed with 2 ml of the preincubation or incubation
medium. The separation, quantitation and measurement of
radioactivity of glutamate, glutamine, aspartate and GABA
were made as described above.
RESULTS

In vivo
The combination of single doses of pargyline and LDOPA resulted in profound physiological changes in

the treated animals, e.g. ruffled fur, splaying of the rear
extremities, Straub tail, tachypnia, diuresis and ejacu~
lation. Neither drug alone had any such effects.

Effect on amino acid levels in rat brains in vivo
There were marked changes in the levels of amino
acids in the brains of rats injected with pargyline and
L-DOPA. The concentration of aspartate was decreased by approx. 20 per cent in all brain areas as well
as in cervical spinal cord (Table I). Glutamine was increased by 10-20 per cent in all areas. The glutamine
increase was statistically significant in all areas except
in brain stem. GABA was slightly increased in the cerebellum. Glutamic acid was slightly decreased in the
brain stem.
In vivo labelling of amino acids by [l- 14C]acetate
Only in brain stem and cerebellum were there significant differences in the labelling of amino acids in
treated animals. The percentage incorporation of
1
[ *C]acetate into total amino acids glutamate and
glutamine in these areas and cortex is illustrated in
Table 2. In cerebellum and brain stem there was significantly less incorporation of radioactivity into
amino acids. In cortex (and other areas), this trend was
not observed. This decrease was also apparent in the
percentage incorporation into glutamic acid and, especially, glutamine. Consistent with t.hese results, the
relative specific activity (RSA) of glutamine to glutamate was decreased in the treated animals compared
to controls in cerebellum at 30 min (2·62 vs 3·66) and
in brain stem at 10 (3·23 vs 4·68) and 20 min (3·12 vs
1

3-43).

Effects on amino acid levels in vitro
Addition of l mM L-DOPA to preincubation and incubation n1edia caused a 25 per cent decrease in the
concentration of glutamine in guinea pig cortical slices
(Table 3). Slices from animals which had been administered pargyline manifested higher levels of aspartate
and GABA than did those from control animals. When
slices from pargylinized guinea pig were incubated
with 1 mM L-DOPA, GABA and glutamine levels were
significantly increased by 10 and 30 per cent respectively, whereas glutamate levels decreased; the concentration of aspartate did not change. The level of
glutamine in the pargylinized slices in the presence of
L-DOPA was more than 50 per cent greater than in the
control slices treated with L-DOPA. In addition,
although glutamate levels were lowered by L-DOPA
after pargyline pretreatmen~ the total amount of
amino acids were higher than in control slices with or
without L-DOPA because of substantial increases in
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TABLE J. EFFECT OF INTRAPERITONEALLY-ADMlNISTERED L-DQPA AND PARGYLINE ON AMINO ACID LEVeLS IN RAT BRAIN
~-tmol/g

tissue + S.E.

Glutamate

Glutamine

Aspartate

12·53 + 0·37
( 11)

4·21 + 0·16
(12)

3·56 + 0·16
(12)

1·71

12·49 + 0·37
(8)

4·15 + 0·15

3·08 + 0·14
(8)

J ·48 + 0·11
(8)

21·20 + 0·62
(8)

DOPA+
Pargyline

12·37 + 0·29
(17)

4·75

2·93 + 0·10
(16)2

1·53 + 0·13
(15)

21·98 + 0·37
( 14)

Cerebellum
Saline
Control

12·49 + 0·33
(J 2)

5·57 + 0·31
(12)

2·43 + 0·12
(12)

1·72 + 0·12
(11)

22·45 + 0·70
( 11)

12·35 + 0·28
(8)

5·54 + 0·37
(8)

2·37

+ 0·12

(8)

(8)

21·78 + 0-49
(8)

12·90 + 0·34
(17)

6·67 + 0·26 2
( 17)

2·02 + 0·06 2
(16)

1·92 + 0·07 2
( 15)

1.1-55 + 0·60 2
( 14)

7·54 + 0·20
(12)

3·45 ± 0·15
(12)

2·73 + 0·09
(12)

1·83 + 0·14
(11)

15·34 + 0·36
(lO)

7·24 + 0·23
(8)

3·20 + 0·11
(8)

2·61 + 0·09

1·67 + 0·08
(8)

14·72 + 0-47
(8)

3·63 + 0·18
(16)

2·20 + 0·07 2
( 16)

1·84 + 0·09
(15)

15·13 + 0·35
( 14)

Cerebral cortex
Saline
Control
Pargyline

Pargyline
DOPA +
Pargyline
Brain stem
Saline
Control
Pargyline

(8)

+ 0·16 2
( 16)

1

+ 0·05

(8)

Total

GABA

± 0·17
( 11)

1·52

-

22·00 + 0·50
(10)

DOPA+
Pargyline

7·22+0·17
( 17)

Hypothalamus
Saline
Control

9·39 + 0·33
(12)

4·95 + 0·16
( 12)

3·03 + 0·13
(12)

3·38 + 0·18
(11)

20·93 + 0-49
( 11)

9·14 + 0·18
(8)
9·26 + 0·23
(17)

4·92 + 0·19
(8)
5·74 + 0·19 2
( 16)

2·81+0·10
(8)
2-45 + 0·05 2
( 16)

3·44 + 0·32
(8)
3·62 + 0·14 1
( 14)

20·31 + 0·38
(8)
21·04 + 0·32
(14)

10·64 + 0·21
(12)

4·63 + 0·17
(12)

2·17 + 0·11
(12)

2·00 + 0·18
(11)

19-36 + 0·50
(11)

Pargyline

10·28 + 0·11
(8)

4·90 + O·ll
(8)

1·86 + 0·10
(8)

1·73 + 0·15
(8)

18·77 + 0·20
(8)

DOPA+
Pargyline

10·32 + 0·28
(17)

5·51 + 0·23 1
( 15)

1·69

( 14)

1·70 + 0·17
( 14)

19·01 + 0·54
(12)

Cervical cord
Saline
Control

4·64 + 0·12
(12)

2·78 + 0·13
(12)

2·13 + 0·09
(12)

1·18 + 0·12
(10)

10·86 + 0·28
(10)

4·39 + 0·14
(8)

2·65 + 0·10

1·72 + 0·25
(7)

0·80 + 0·10
(8)

9·56 + 0·30
(8)

4·75 + 0·14
(16)

3·06

1· 75 + 0·0~)-~
( 15)

1·16 + 0·11
(14)

10·91 + 0·38
(12)

Pargyline
DOPA+
Pargyline
Striatum
Saline
Control

Pargyline
DOPA+
Pargyline
1

(8)

+ 0·09 2
(16)

+ 0·07 1

P <" 0·05 from '\al inc t.:ontrol-.;.
~ P < 0·0 I from ~almc controls.
(N) is number of animals.
Rats (175-200g) were injected intraperitoneally with pargyline (lOOmgj kg) in isotonic saline. L-DOPA (IOOmgfkg) was
similarly administered 30 min later (see Methods for preparation of L-OOP A soln). Control animals received similar
volumes of saline. At periods ranging from 20 to 45 min after L-DOPA (or saline), the rats were decapitated, the brains
divided into various areas, frozen in liquid nitrogen and amino acids extracted and determined.
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TABLE 2. LABELLING

Area
Cortex

Cerebellum

Brain stem

Cortex

Cerebellum

Brain stem

OF

Time
(min)

AMINO ACIDS IN RAT BRAIN in Vil'O FROM [J- 14C]ACETATE Al-TER TREATMPH WITH PARGYLINE AND L-DOPA

% Incorporation

c.p.m. g tissue x 10 4
in TCA extract
Treated
Control

in amino acids
Control
Treated

10
20
30
10
20
30
10
20
30

3·05 + 0·55
2·64 + 0·37
2·88 + 0·04
4·70 + 2·61
7·23 + 1·72
5·48 + 0·56
1·91 + 0·31
3·04 + 0·87
5·24 + 1·04

10
20
30
10
20
30
10
20
30

%Incorporated
into glutamate
Treated
Control
32·3 + 4·6
25·7 + 2·8 1
36·2+1·1
28·0 + 3·3
34·4 + 2·3
32·1 + 6·1
22·4 + 2·7
17·0 + 4·1
16·2 + 7·2
5·5 + 0·4 1
12·1 + 1·0
10·7 + 2·3
13·2 + 4·6
15·7 + 3·4
19·3 + 4·8
6·0 + 1·9 1
8·2 ± 1·9
9·6 + 2·0

3·75 + 0·32
3·13 + 0·41
3·35 + 0·26
5·19 + 2·06
11·4 + 1·11
8·38 + 0·81
3·00 + 0·92
6·51 + 1·57
4·85 + 0·57

70·2 + 8·3
78·4 + 0·1
66·1 + 3·9
41·0+5·7
37·0 + 0-4
37·6 + 5·3
54·2 + 3·8
53·8 + 8·1
29·3 + 3·1

65·4 + 10·2
68·2 + 8·2
67·8 + 8·8
37·3 + 7·5
18·1 ± 1·1 2
22·9 + 4·5 2
30·X + 4·21
18·9 + 6·2 2
26·0 + 7·0

% Incorporated
into glutamine
Control
Treated
36·1 + 3·1
37·6 + 5·5
35·6 + 0·7
33·3 + 4·6
25·8 + 2-4
22·0 + 2·8
18-4 + 2·7
27·6 + 7·2
16·1 + 0·3
11·3 + 0·61
21·8 + 3·1
14·4 + 3·22
36·3 + 7·3
19·3 + 3-4 1
26·4 + 6·5
10·8 ± 2·3 1
16·3 + 3·5
12·2 + 3·6

1

2
Different from control P < 0·05.
Different from control P < 0·0 l.
Rats were injected with pargyline and L-DOPA as outlined in Table I. 15 min after L-DOPA
(or saline in controls), [ I- 14C]acetate in saline 250 ,uCi/ kg, 42 ,uCi/,umol was administered intraperitoneally. At time periods indicated, the rats were decapitated and brain samples taken as
outlined in Table I and in Methods section of the text. Amino acid were extracted from the
frozen tissue with 5°~ trichloroacetic acid (TCA). separated by ion-exchange chromotography,
quantitated with ninhydrin and radioactivity measured by scintillation spectrometry. The
values are the means + s.E. for two to four animals at each time point.

TABLE

3.

Control
Control+
L-DOPA
Pargylinized
Pargylinized
+ L-DOPA
1

FROM
L-DOPA

CONCENTRATIO"'lS OF AMINO ACIDS L" BRAIN SLJC'ES

NORMAL A:-.:D

PARGYLI'IIZED

GUINEA PIGS: EFFECT OF

Glutamate

Glutamine

(,umoljg wet wt)
Aspartate

8·53 + 0·13
(30)

2·25 + O·ll
(30)

1·73 + 0·06
(30)

2·57+0·13
(30)

15·08 + 0·26
(30)

8·66 + 0·17
(12)
8·36 + 0·14
(10)

1·61 1 + 0·07
{l2)
2·03 + 0·21
(10)

1·72 + 0·11

2·58 + 0·20
(I 2)
3·36 1 + 0·36
(10)

14·58 + 0·36
( 12)

8·02 + 0· I 72 •3
(J 0)

2·63 + 0·17 2 ·3
(10)

( 12)

2·36 1 + 0·08
(l 0)

2·36 + 0·07 1• 5
(I 0)

GABA

Total

3·96 + 0·221. 4
(10)

16·1 I 1 + 0· 38
(I 0)
16·97 :t 0·42'·3
(I 0}

1
3
P < 0·01 from control.
P < 0·05 from control.
P < 0·01 from pargyline.
4
5
P < 0·05 from pargyline.
P < O·OJ from control + DOPA.
Guinea pigs were injected with pargyline (100 mg/kg) in isotonic saline. Thirty min later the animals were decapitated
and slices of cerebral cortex were prepared. The slices (60-80 mg wet wt) were preineubated in 2·5 ml Krebs Ringer bicarbonate medium fortified wtth 55 mM glucose for J 5 min at 37 C. The slice then was transferred to 2·5 ml fresh medium and
2·5 ,uCi[l- 14-C]acetate (421tCi ,umol) was added. After incubation for 5, 10 or 20 min the slices were removed from medium,
washed vvith saline and homogenized in icc-cold 5~0 TCA. The ammo acids were eJ~.tracted and quantitated. In some cases.
1 mM L-DOPA was present in both preincubation and incubation media. The values are expressed as the means + s.r:. for
the number of slices indicated. Since there were no obvious changes in levels with time, the values for each treatment were
pooled.
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TABLe 4. lNCORPORt\TION OF [ 1- 14C]ACETATE INTO AMINO AC'IDS TN GUINEA PIG BRA IN SLIC'ES

%Incorporation

c.p.m.jg tissue x 10- 6
in TCA extract

5 min
1·07 + 0·07
Control
Control + 1 -DOPA 1·06 + 0·01
Pargylmc + L-DOPA 1·56 + 0·12 1
1-43

+ 0·11 1

10 min

5 min

15 min

+ 0·1 J
1·23 + 0·07
2·19 + 0·08 1
1·47

2·12

into amino acids

+ 0·07 1•3

2·14 + O·IH
2·00 + 0·04
3·41 + 0·18 1
2·77 + 0· J32 .4

24·2
21·8
37·9
32·9

10 min

+ 3·0
+ 0·6
+ 4·0
+ 5·0 1

33·5
33·9
.f5·J
-ll·n

+ 3·7
+ 2·3

=

J-0~

+ 4·7 2

15 min

43·7 +
47·5 +
60·0 .J55·3 +

4·4
1·3
I ·J 2
8· I 2

2
Differe nt from control, P < 0·0 I.
Different from control. P < 0·05.
4
-' Different from control plus DOPA. P < 0·01.
Different from control plus DOPA. P < 0·05.
Guinea pig brain slices '.\ere prepared and treated as indicated in Table 3 and in the Methods section of the text. The
total radioactivity in the tissue (c.p.m.jg wet wt) was obtained by counting an aliquot of the trichloroacetic acid (TCA)
extract. The percentage incorporation into amino acids is the percentage of this total radioactivity which was found in
the sum of c.p.m.jg tissue in glutamate, glutamine, aspartate and GABA. The results are expressed as the means +s.c. for
two to six samples at each time point.
1

the levels of aspartate and GABA. There was no evidence that treatment with pargyline and/ or L-DOPA
caused changes in the leakage of amino acids from the
slices into either the preincubation or incubation
media.

Labelling of amino acids in vitro
Although 1 mM L-DOPA lowered glutamine levels
in control slices, there were no concomitant profound
changes in the labelling of amino acids from [ 1-

14

C]acetate (Tables 4 and 5, Figs. 1A, l C, 2A, 2C). The
specific activity of glutamate and its increase with time
of incubation were not affected at all by L-DOPA.
However, the initial labelling of glutamine, aspartate
and GABA were somewhat decreased. By 20 min of incubation there were no differences in the specific activities of these amino acids between control and LDOPA treated slices. The large differences in the percentage distribution of incorporated radioactivity in
glutamate and glutamine after L-DOPA (Fig. 3A and

TABLE 5. RELATIVE SPEC'lFIC ACTIVITY OF GLUTAMINE, ASPARTATE AND GABA
BRAIN SLICES INCUBATED WITH [l- 14C)ACETATE

Control
Control+ DOPA
Pargyline
Pargyline + DOPA
Control
Control +DOPA
Pargyline
Pargyline + DOPA
Control
Control + DOPA
Pargyline
Pargyline + DOPA
1

I"''

GUINJ.A PIG

5 min

10 min

20 min

4·64 + 0·44
3·27 + 0·51
3-46 + 0·33 2
1·08 + 0·03 1

Glutamine
5·50 + 0·73
5-45 + 1·61
2·41 ± 0·27 1
1·15 + 0·08 1

4·20 + 0·64
5·78 + 0·19
1·00 + 0·45 1
0·81 + 0·27 1

0·31 + 0·07
0·16 + 0·02
0·20 + O·OJ
0·23 + 0·02

Aspartate
0·34 + 0·06
0·27 + 0·01
0·26 + 0·01
0·25 + 0·03

0·47 + 0·03
0·48 + 0·00
0·36 + 0·02 2
0·36 + 0·02 2

+ 0·02
+ 0·05
+ 0·03
+ 0·01

GABA
0·26 + 0·06
0·19 + 0·04
0·09 + 0·01
0· 10 + 0·01

0·3 1 + 0·05
0·31 + 0·01
0·18 + 0·02
0·15 + 0·06 1

0·12
0·11
0·10
0·07

1
Different from control, P < 0·0 1.
Different from control, P < 0·05.
See Tables 3 and 4 for details of incubation. The amino acids in the TCA extract were separated by ion-exchange chromatography and quantitated with ninhydrin. An aliquot of the main
fraction of each amino acid was counted by liquid scintillation spectrometry to determine the
specific radioactivity (c.p.m./Jlmol}. These specific activities (sec Figs. 1 and 2) are tabulated relative to that of glutamic acid. The results are expressed as means +s.E. for two to six slices at
each time point.
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C) are therefore primarily due to the decrease in the
pool size of glutamine.
In the slices prepared from pargylinized animals
there was an apparent increased incorporation of [114C]acetate into amino acids as evidenced by a substantial increase in both the total radioactivity in TCA
extracts at all time points as well as an increase in the
amount of this radioactivity isolated in the amino
acids (Table 4). There was also a more rapid labelling
of amino acids. especially glutamate and aspartate, in
these slices compared to controls (compare A with B
and C with D in Figs. l and 2). Glutamine was also
more rapidly labelled but its specific activity levelled ofT
by 10 min of incubation. The specific activity of GABA
did not increase with the same rapidity as did the specific activities of glutamate and aspartate. These differences were even more apparent in the relative specific
activities (RSA, glutamate = 1) (Table 5). In the controls, the RSA of glutamine remained high during the
entire 20 min of incubation. On the other hand, in the
slices from pargylinized animals, the RSA of glutamine
was high at 5 min but fell off to 1 at 20 min. The RSA
of aspartate was not affected appreciably by pretreatment of the animal with pargyline. However, in the
slices from the latter animals, the RSA of GABA did
not increase with time as in the control slices. Pargy-
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1. Specific radioactivities of glutamate (A. B) and glutamine (C. D) in guinea pig brain slices incubated with [l14C]acetate. In Band D, the animals were pretreated with
pargyline 30 min prior to preparation of the slices. The slices
were incubated with (open circles) or without (closed circles)
1 mM L-DOPA. See Tables 3, 4 and 5 for experimental
details. The means of two to six slices at each time point are
plotted; the vertical bars represent the s.E.
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2. Specific radioactivities of aspartate (A, B) and
GABA (C, D) in guinea pig brain slices incubated with [114C]acetate. In Band D, the animals were pretreated with
pargyline 30 min prior to preparation of the slices. The slices
were incubated with (open circles) or without (closed circles)
1 mM L-DOPA. See Tables 3, 4 and 5 for experimental
details. The means of two to six slices at each time point are
plotted; the vertical bars represent the s.E.
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liniLation had a drastic effect on the distribution of
total amount of radioactivity amongst the amino acids
(Figs. 3 and 4; compare A with B and C with D). The
percentage of incorporated radioactivity in glutamate
was much greater in the pargylinized slices than in
controls and increased with time (Fig. 3) even though
the level of glutamate was not altered by such treatment (Table 3). The increased percentage of radioactivity in aspartate was even more pronounced (Fig. 4)
reflecting both an increase in the rate of labelling as
well as an increase in total pool size. These increases
were at the expense of the glutamine pool since the percentage of incorporated radioactivity fell rapidly with
time (Fig. 3): there was no change in the total pool size
of glutamine during this interval. The distribution of
radioactivity into GABA was apparently not altered
by the pargyline pretreatment in spite of an increased
pool size.
The addition of I mM L-DOPA to the brain slices
from the patgylinized guinea pigs, on the other hand,
caused large changes in the labelling of amino acids
(especially glutamine) from [l- 14C]acetate. In spite of
an increase in the pool size of glutamine, the specific
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3. Percentage distribution of radioactivity of total
amino acids in glutamate (A, B) and glutamine (C, D) in
guinea pig brain slices incubated with [1- 14C]acetate. The
total radioactivity incorporated into these amino acids was
taken as 100 per cent (see Table 4). In Band D. the animals
were pretreated with pargyline 30 min prior to preparation
of the slices. The slices were incubated with (open circles) or
without (closed circles) 1 rnM L-DOPA. See Tables 3, 4 and
5 for details. The means of two to six slices at each time
point are plotted; the vertical bars represent the S.E.
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4. Percentage distribution of radioactivity of total
amino acids in aspartate (A, B) and GABA (C, D) in guinea
pig brain slices incubated with [l- 14C]aceta te. The total
radioactivity incorporated into these amino acids was taken
as 100 per cent (see Table 4). In B and D, the animals were
pretreated with pargyline 30 min prior to preparation of the
slices. The slices were incubated with (open circles) or without (closed circles) l mM L-DOPA. See Tables 3, 4 and 5 for
details. The means of two to six slices at each time point are
plotted; the vertical bars represent the s.E.
FIG.

DISCUSSION

activity of this amino acid was greatly depressed from
that in the pargylinized slice at 5 and 10 min of incubation~ at 20 min there were no apparent differences
(Fig. lD). The enhanced specific activity of glutamate
and aspartate by pargyline was not affected by LDOPA (Figs. lB and 2B). At 20 min incubation in the
pargylinized slice, the RSA of glutamine was 1; in the
slices incubated with L-DOPA, the RSA of glutamine
was already 1 at 5 min and remained at that ratio
throughout the incubation periods (Table 5). Since the
L-DOPA had no effect on either the amount of
radioactjvity in the tissue nor its incorporation into
total amino acids (Table 4), the percentage distribution
of the incorpora ted radioactivity among the amip.o
acids is reflective of the effects on pool sizes and specific activities. The percentage radioactivity in glutamate, aspartate and GABA were increased in the
DOPA-treated slices from pargylinized animals (especially at 5 and 10 min), whereas that in glutamine was
decreased (Figs. 3B, 30 and 4B, 4D). By 20 min incubation there were no discernible differences in labelling between control and DOPA-treated slices.

The compartmentation of amino acid metabolism in
the brain is well documented (for reviews, BERL &
CLARKE, 1969; VAN DEN BERG, 1970). Biochemical and
computer simulation studies have led to suggestions
concerning the correlations between these various
compartments and morphological structures (BALAzS
et al., 1970; BALAzS et al., 1973; GARFINKEL, 1973; VAN
DEN BERG & GARFINKEL, 1971; VAN DEN BERG, 1973).
4
C]Acetate, for example, is thought to be activated
and enter the TCA cycle primarily in the glia. There it
labels a small poo] of glutamate from which glutamine
is synthesized. This gives rise to the high specific activity of glutamine relative to the glutamate isolated
from the whole tissue. BALAzS et al. (1970, 1973) have
proposed a three-compartment model consisting of
glia, nerve endings and perikarya (including, perhaps,
dendrites). This simple model will be used in discussing
the results of the present studies.
TvcF ( 1971) has shown that the combination of LDOPA and a n1onoamine oxidase inhibitor (/3-phenylisopropylhydrazine) decreases aspartate levels, increases the levels of glutamine and GABA in whole ra1
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brain and decreases the flow of radioactivity into
amino acids from [ 14C]glucose. The combination of
pargyline and L-DOPA gave similar changes in levels
in isolated brain areas (Table 1); pargyline was used
since the presence of a hydrazine-type inhibitor raises
the question of possible direct interactions with amino
acid metabolism via reaction with pyridoxal phosphate (Porov & MATIHIES, 1969). This combination of
drugs greatly decreased the incorporation of radioactivity into atnino acids from [ 14C]acetate in vivo, especially into cerebellum and brain stem (Table 2). Glutatnine was more affected than was glutamate in that the
RSA of g1utamine was somewhat lowered. Liu et a!.
( 1972) have shown that chronic treatment with LOOPA alone causes a significant decrease in glutamine
levels in rat brain. It should be noted that treatment
with L-DOPA causes increased levels of certain amino
acids in the CSF of Parkinsonian patients (KREMZNER
et al., 1972).
The in vivo data with L-DOPA then, would indicate
an alteration in amino acid metabolism with a special
impairment of glutamine. The decrease in glutamine
levels in slices treated with L-DOPA is similar to that
seen in vivo (LIV et al., 1972). L-DOPA apparently
causes this change in steady state levels by decreasing
the rate of glutamine formation in all compartments.
The combination of a decreased rate of synthesis with
decreased pool size accounts for the small changes
observed in its labelling by [l- 14C]acetate. Labelling
of glutamine b} [2- 14C]glucose, which labels the 'large'
compartment as well as the 'small' compartment, is
n1uch more inhibited by L-DOPA in slices (unpublished observations) than was that from C4 C]acetate.
L-DOPA would appear to exert its effect either directly, by stimulating formation of dopamine or by
releasing the monoamines from presynaptic stores (No
et al., 1971) and these interact with the glial as well as
neural metabolism of glutamine.
Based on previously published studies (VALZELLI &
GARRATTINI, 1968), it is assumed that pargyline has its
major effect in nerve endings where it elevates the
endogenous levels of catecholamines. In agreement
with that assumption, pargyline stimulates the labelling of metabolites in the 'large' compartment which is
thought to consist of nerve endings and/or perikaryia;
the relative labelling of glutamine is inhibited compared to the increased rate of labelling of glutamate
and aspartate. The decrease in glutamine labelling may
not be due solely to an increase in nerve ending metabolism relative to glia. Another possibility is that
stimulation of cyclic AMP formation by catecholamincs may deplete that portion of the ATP stores normally used for glutamine synthesis. Other direct effects
on glial metabolism also require further consideration.

D. D.

CLARKE

The latter hypothesis is made more tenable by the
observations that noradrenaline greatly stimulates cyclic AMP formation in glial cu ltures (AMANO et al.,
1972).
The effects of the combination of L-DOPA plus pargyline then may be due to a relative stimulation of
nerve ending and perikarial metabolism due to increased levels and synthesis of catecholamines coupled
with an increased efflux of catecholamines from nerve
ending stores by L-DOPA or its n1etabolites. The increase in glutamine levels and the fact that GABA
labelling does not follow that of glutamate and aspartate are consistent with postulated counter-flow of glutamine and GABA between compartments, i.e. a flow
of glutamine from glia to neurones and the reverse for
GABA, which is necessary for maintenance of nitrogen
balance (VAN DEN BERG & GARFINKEL, 1971 ~ BALAzS
et al., 1970, 1973). The great differences in labelling
between slices and the in vivo situation may be due to
several factors: ( 1) brain slices have no electrical activity, decreased respiration and increased RSA's of glutamine indicating a preponderance of glial metabolism
over that of nerve endings in slices. The release of
metabolites associated with electrical activity appears
to provide flux of material between compartments
which compensate for the pool alterations produced
by drug treatment. Therefore the changes in the labelling patterns of the amino acids arc less dramatic in
vivo than in vitro. In addition the radioactive acetate is
administered as a pulse in vivo and as a constant feed
in the medium in vitro; (2) the glutamate and glutamine levels are lower in slices because of leakage and/
or metabolism during preparation and incubation; and
(3) increased levels of GABA in the slices due to postmortem effects.
It is not clear from these experiments whether the
effect of the L-DOPA on the slices (especially after pargylinization) is due to the L-DOPA itself, its metabolites or is a general property of amino acids added at
relatively high concentrations (1 mM) to the medium.
Further work on the transport of L-DOPA and utilization of inhibitors of its metabolism will be needed to
clarify this specific situation. What is clear from experiments such as those described here is that, in spite of
the great morphological and metabolic complexity of
brain, one can demonstrate the rapid response of one
metabolic compartment to another, e.g. glia, to events
which occur in another compartment, e.g. nerve endings. Studies with simpler systems, such as tissue cultures or isolated ganglia, may be most useful in
delineating the time scale of such interactions and
further clarifying the exact nature of the biochemical
mechanisms involved.
The data suggests that catecholamines. in the pro-

Pargyline, L-DOPA and brain amino acids

cess of functioning as transmitters, may also function
as metabolic regulators of other transmitters, e.g.
amino acids, as well as of the generation of the energy
required for balanced neuronal function. Thus the
turnover of small amounts of catecholamines can control the turnover of large amounts of amino acids
which are associated with tricarboxylic acid cycles as
part of a feedback amplifier control system.
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